GovWire

Decision: CAP bridging mechanism products

Medicines Healthcare Products Regulatory Agency

May 29
09:35 2024

The CAP bridging list comprises:

A GB licenced product (PLGB) to Northern Ireland for a period of 6 months or until the EC authorises a CAP in Northern Ireland or the EC refuses an application for the product, whichever is sooner.

For further information, read our CAP bridging mechanism guidance.

Published 6 September 2023
Last updated 29 May 2024 +show all updates
  1. Moved 'Tecentriq 1,875 mg solution for injection' to expired CAP bridging list

  2. Moved 'Casgevy 4-13 x 10^6 cells/mL dispersion for infusion' to Expired CAP Bridging list

  3. Active CAP Bridging List updated with new entry: Casgevy

  4. First published.

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: